Morgan Stanley Initiates Coverage On Imax with Overweight Rating, Announces Price Target of $63

Morgan Stanley analyst Daniel Duran has initiated coverage on Imax (NYSE: IMAX) with an Overweight rating. The firm has set a price target of $63 for the stock.